Long-term efficacy of TARGIT-IORT for breast cancer confirmed
The long-term results of the randomised trial testing the revolutionary procedure - TARGIT-IORT were published by the British Medical Journal on 19 August 2020
Single dose radiotherapy given during lumpectomy for breast cancer (TARGIT-IORT) was found to be as good as conventional post-operative radiotherapy for most women with early breast cancer.
In addition, TARGIT-IORT leads to fewer deaths from causes other than breast cancer, such as heart attacks, lung problems and other cancers.
A short video explains the results
Here is the press-release from University College London that explains the results
https://www.ucl.ac.uk/news/2020/aug/single-dose-radiotherapy-effective-treating-breast-cancer
The scientific summary is shown below - click on it to see the original paper on the BMJ website.
These results were widely reported in the media such as the lead article in the Times, London, UK, and on social networks
